Franzese O, Torino F, Giannetti E, Cioccoloni G, Aquino A, Faraoni I
Int J Mol Sci. 2021; 22(19).
PMID: 34639014
PMC: 8509363.
DOI: 10.3390/ijms221910672.
Franzese O, Torino F, Fuggetta M, Aquino A, Roselli M, Bonmassar E
Oncotarget. 2017; 8(25):41641-41669.
PMID: 28404974
PMC: 5522228.
DOI: 10.18632/oncotarget.16335.
Killion J, Radinsky R, Dong Z, Fishbeck R, Whitworth P, Fidler I
Cancer Immunol Immunother. 1993; 36(6):381-6.
PMID: 8098991
PMC: 11038117.
DOI: 10.1007/BF01742254.
Franco P, Veronese F, Levi F, Goldin A, Nicolin A
Br J Cancer. 1982; 46(2):173-9.
PMID: 7150471
PMC: 2011101.
DOI: 10.1038/bjc.1982.181.
Calvelli T, Freedman V, Silverstein S, Silagi S
J Exp Med. 1982; 156(6):1723-38.
PMID: 6983560
PMC: 2186874.
DOI: 10.1084/jem.156.6.1723.
Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.
Kerbel R, Dennis J, Largarde A, Frost P
Cancer Metastasis Rev. 1982; 1(2):99-140.
PMID: 6764377
DOI: 10.1007/BF00048223.
Intratumor immunologic heterogeneity.
Miller F
Cancer Metastasis Rev. 1982; 1(4):319-34.
PMID: 6192904
DOI: 10.1007/BF00124215.
In vivo characterization of a doxorubicin resistant B16 melanoma cell line.
Formelli F, Rossi C, Supino R, Parmiani G
Br J Cancer. 1986; 54(2):223-33.
PMID: 3741758
PMC: 2001516.
DOI: 10.1038/bjc.1986.166.
Chemical xenogenization of experimental tumors.
Puccetti P, Romani L, Fioretti M
Cancer Metastasis Rev. 1987; 6(2):93-111.
PMID: 3297373
DOI: 10.1007/BF00052845.
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.
Marelli O, Franco P, Canti G, Ricci L, Prandoni N, Nicolin A
Br J Cancer. 1988; 58(2):171-5.
PMID: 2458749
PMC: 2246753.
DOI: 10.1038/bjc.1988.186.
A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapy.
Satoh K, Kan N, Okino T, Nakanishi M, Mise K, Teramura Y
Cancer Immunol Immunother. 1991; 32(5):273-9.
PMID: 1998969
PMC: 11038032.
DOI: 10.1007/BF01789044.
Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells.
Reif A, Robinson C
Immunology. 1975; 28(1):199-205.
PMID: 1090519
PMC: 1445768.
Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo.
Nicolin A, Fagnani R, Nicolotti G, Goldin A
Experientia. 1976; 32(6):741-2.
PMID: 780128
DOI: 10.1007/BF01919863.
Chemotherapy, a double agent in respect of immune functions.
MATHE G
Cancer Chemother Pharmacol. 1978; 1(2):65-8.
PMID: 750105
DOI: 10.1007/BF00254037.
